GlassScriptPhysician profile
Mirela Krasniqi
NPI 1801113733
$5,925.76
in general payments reported to CMS, 2019-2025
23 companies · $1,358 in 2025
The $1,358 reported for 2025 was more than what 83% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $216 · 2021: $221 · 2022: $833 · 2023: $1,214 · 2024: $1,703 · 2025: $1,358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,275.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,431.39 | 2022-2025 | |
| Alcon Vision LLC | $804.62 | 2019-2025 | Clareon, Rocklatan, Clareon Panoptix Pro |
| Sight Sciences, INC. | $469.47 | 2020-2024 | Omni Surgical System |
| Glaukos Corporation | $376.68 | 2023-2025 | Idose, Idosetr, Istent Trabecular Micro-Bypass System Model Is3 |
| Nova Eye, INC. | $290.13 | 2023-2024 | |
| Harrow Eye, LLC | $258.43 | 2024-2025 | |
| Ocular Therapeutix, INC. | $190.92 | 2021-2025 | Dextenza |
| Oyster Point Pharma, INC. | $179.76 | 2022-2024 | Tyrvaya, Ryzumvi |
| Sun Pharmaceutical Industries INC. | $156.14 | 2019-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $132.62 | 2019-2025 | Tecnis Iol, Tecnis Iol |
| Bausch & Lomb Americas INC. | $109.99 | 2022-2025 | Xiidra, Ic-8 Apthera Iol |
| Novartis Pharmaceuticals Corporation | $87.16 | 2019-2022 | |
| Allergan, INC. | $86.16 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $85.62 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $77.14 | 2019-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $42.90 | 2022-2024 | Omidria, Rayone Emv, Rayone Aspheric |
| Thea Pharma INC. | $30.98 | 2025 | Iyuzeh |
| Johnson & Johnson Vision Care, INC. | $25.09 | 2021 | |
| Dompe US, INC. | $23.48 | 2025 | Oxervate |
| Rxsight INC | $20.51 | 2023 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Amgen INC. | $18.57 | 2024 | Tepezza |
| Coopervision INC. | $14.49 | 2021 | |
| Ivantis, INC | $13.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mirela Krasniqi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.